Keyword

MLi-2

Description: A potent, selective small-molecule inhibitor of the LRRK2 kinase, used in biomedical research on Parkinson’s disease and lysosomal function.
OpenAlex ID: keywords/mli-2
2015 · Matthew J. Fell, Christian Mirescu, et al. · Journal of Pharmacology and Experimental Therapeutics · 336
2016 · L. A. Volpicelli-Daley, H. Abdelmotilib, et al. · Journal of Neuroscience · 208
2019 · Rebecca Wallings, Natalie Connor-Robson, et al. · Human Molecular Genetics · 121
2021 · Anna Tasegian, Francois Singh, et al. · Biochemical Journal · 75
2021 · Sven H. Schmidt, Jui-Hung Weng, et al. · Proceedings of the National Academy of Sciences · 69
2023 · Matthew G Williamson, Marta Madureira, et al. · Human Molecular Genetics · 65
2023 · Marta Sanz Murillo, Amalia Villagran Suarez, et al. · Science Advances · 59
2019 · Michael X. Henderson, Medha Sengupta, et al. · Acta Neuropathologica Communications · 51
2024 · Nicholas Pena, Tara Richbourg, et al. · npj Parkinson s Disease · 37
2021 · Charlotte F. Brzozowski, Baraa A. Hijaz, et al. · Acta Neuropathologica Communications · 35
2021 · Dong Hwan Ho, Daleum Nam, et al. · Oxidative Medicine and Cellular Longevity · 34
2023 · Elżbieta Kania, Jaclyn S. Long, et al. · Cell Death and Disease · 31
2024 · Noah Lubben, Julia K. Brynildsen, et al. · Translational Neurodegeneration · 23
2021 · Salvatore Novello, Daniela Mercatelli, et al. · Neurobiology of Disease · 23
2021 · Jessica M. Bright, Holly J. Carlisle, et al. · Movement Disorders · 23
2020 · Lindsey M. Crown, Mitchell J. Bartlett, et al. · Frontiers in Neurology · 12
Works count: 105
Citation count: 1,731
Year
Topic
Type